These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. Moolgavkar SH, Day NE, Stevens RG. J Natl Cancer Inst; 1980 Sep; 65(3):559-69. PubMed ID: 6931935 [Abstract] [Full Text] [Related]
4. Risk factors for endometrial cancer at different ages. La Vecchia C, Franceschi S, Decarli A, Gallus G, Tognoni G. J Natl Cancer Inst; 1984 Sep; 73(3):667-71. PubMed ID: 6590913 [Abstract] [Full Text] [Related]
5. [Female sex hormones increase the risk of breast cancer]. Vatten L. Tidsskr Nor Laegeforen; 1998 Aug 20; 118(19):2969-74. PubMed ID: 9748837 [Abstract] [Full Text] [Related]
6. Epidemiology of susceptibility to breast cancer. Hulka BS. Prog Clin Biol Res; 1996 Aug 20; 395():159-74. PubMed ID: 8895988 [Abstract] [Full Text] [Related]
7. Multistage carcinogenesis modeling and the initiation event. Chadwick KH, Leenhouts HP. Radiat Oncol Investig; 1997 Aug 20; 5(3):129-33. PubMed ID: 9303070 [Abstract] [Full Text] [Related]
8. Endocrine factors in human carcinogenesis. Armstrong B. IARC Sci Publ; 1982 Aug 20; (39):193-221. PubMed ID: 6759385 [Abstract] [Full Text] [Related]
10. Symmetry, identifiability, and prediction uncertainties in multistage clonal expansion (MSCE) models of carcinogenesis. Cox LA, Huber WA. Risk Anal; 2007 Dec 20; 27(6):1441-53. PubMed ID: 18093045 [Abstract] [Full Text] [Related]
11. An essay on the nature of hormonal codes involved in the genesis of human neoplasias (review). Kodama M, Kodama T. Anticancer Res; 1994 Dec 20; 14(6B):2653-65. PubMed ID: 7872697 [Abstract] [Full Text] [Related]
12. Distinguishing between models of carcinogenesis: the role of clonal expansion. Kopp-Schneider A, Portier CJ. Fundam Appl Toxicol; 1991 Oct 20; 17(3):601-13. PubMed ID: 1794662 [Abstract] [Full Text] [Related]
13. Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study. Chang-Claude J, Andrieu N, Rookus M, Brohet R, Antoniou AC, Peock S, Davidson R, Izatt L, Cole T, Noguès C, Luporsi E, Huiart L, Hoogerbrugge N, Van Leeuwen FE, Osorio A, Eyfjord J, Radice P, Goldgar DE, Easton DF, Epidemiological Study of Familial Breast Cancer (EMBRACE), Gene Etude Prospective Sein Ovaire (GENEPSO), Genen Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland (GEO-HEBON), International BRCA1/2 Carrier Cohort Study (IBCCS) collaborators group. Cancer Epidemiol Biomarkers Prev; 2007 Apr 20; 16(4):740-6. PubMed ID: 17416765 [Abstract] [Full Text] [Related]
14. Exogenous estrogens and other factors in the epidemiology of breast cancer. Kelsey JL, Fischer DB, Holford TR, LiVoisi VA, Mostow ED, Goldenberg IS, White C. J Natl Cancer Inst; 1981 Aug 20; 67(2):327-33. PubMed ID: 6943372 [Abstract] [Full Text] [Related]
15. Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Wu MH, Chou YC, Yu JC, Yu CP, Wu CC, Chu CM, Yang T, Lai CH, Hsieh CY, You SL, Chen CJ, Sun CA. Ann Epidemiol; 2006 Mar 20; 16(3):223-9. PubMed ID: 15996484 [Abstract] [Full Text] [Related]
16. Menstrual factors in relation to breast cancer risk. Titus-Ernstoff L, Longnecker MP, Newcomb PA, Dain B, Greenberg ER, Mittendorf R, Stampfer M, Willett W. Cancer Epidemiol Biomarkers Prev; 1998 Sep 20; 7(9):783-9. PubMed ID: 9752986 [Abstract] [Full Text] [Related]